Antivirals in the transplant setting
- 30 September 2006
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 71 (2-3) , 192-200
- https://doi.org/10.1016/j.antiviral.2006.04.016
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Transmission of Integrated Human Herpesvirus 6 through Stem Cell Transplantation: Implications for Laboratory DiagnosisThe Journal of Infectious Diseases, 2006
- Reactivation of Epstein-Barr virus from latencyReviews in Medical Virology, 2004
- BK virus‐associated nephropathy in kidney transplant recipientsReviews in Medical Virology, 2004
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood, 2003
- Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infectionBone Marrow Transplantation, 2000
- Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitisAIDS, 1998
- Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantationBlood, 1995
- Laboratory studies of herpes simplex virus strains resistant to acyclovirReviews in Medical Virology, 1991
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979